Key result
Higher rheumatoid arthritis disability was independently associated with increased arterial stiffness, demonstrating a 2.8-point increase in stiffness per 1-point increase in HAQ score.
Why the study?
Does HAQ disability correlate with arterial stiffness in patients with rheumatoid arthritis without overt arterial disease?
Cross-Sectional (n=114)
No
Does HAQ disability correlate with arterial stiffness in patients with rheumatoid arthritis without overt arterial disease?
In patients with rheumatoid arthritis without overt arterial disease, higher disease-related disability is independently associated with increased arterial stiffness, suggesting a link between chronic inflammation, disability, and subclinical atherosclerosis.
May support disability as vascular risk marker in RA; hypothesis-generating and requires prospective validation before clinical use.
OBJECTIVE: To quantify the relationship between Stanford Health Assessment Questionnaire (HAQ) disability and arterial stiffness in patients with rheumatoid arthritis (RA). METHODS: A consecutive series of 114 patients with RA but without overt arterial disease, aged 40-65 years, were recruited from rheumatology clinics. A research nurse measured blood pressure (BP), arterial stiffness (heart rate-adjusted augmentation index), fasting lipids, glucose, erythrocyte sedimentation rate (ESR), and rheumatoid factor (RF). A self-completed patient questionnaire included HAQ, damaged joint count, EuroQol measure of health outcome, and Godin physical activity score. Multiple linear regression (MLR) adjusted for age, sex, smoking pack-years, cholesterol, mean arterial BP, physical activity, daily fruit and vegetable consumption, arthritis duration, ESR, and RA criteria. RESULTS: Mean age was 54 years (81% women) with a median HAQ of 1.13 (interquartile range 0.50; 1.75). Median RA duration was 10 years, 83% were RF-positive, and median ESR was 16 mm/h. Mean arterial stiffness was 31.5 (SD 7.7), BP 125/82 mm Hg, cholesterol 5.3 mmol/l, and 24% were current smokers. Current therapy included RA disease-modifying agents (90%), prednisolone (11%), and antihypertensive therapy (18%). Arterial stiffness was positively correlated with HAQ (r = 0.42; 95% CI 0.25 to 0.56). On MLR, a 1-point increase in HAQ disability was associated with a 2.8 increase (95% CI 1.1 to 4.4; p = 0.001) in arterial stiffness. Each additional damaged joint was associated with a 0.17 point increase (95% CI 0.04 to 0.29; p = 0.009) in arterial stiffness. The relationship between EuroQol and arterial stiffness was not statistically significant. CONCLUSION: In patients with RA who are free of overt arterial disease, higher RA disability is associated with increased arterial stiffness independently of traditional cardiovascular risk factors and RA characteristics.
No takes yet. Share an insight, caveat, or question.
Crilly et al. (2010) conducted a cross-sectional in Rheumatoid Arthritis without overt arterial disease (n=114). Rheumatoid arthritis disability (HAQ score) was evaluated on Arterial stiffness (heart rate-adjusted augmentation index, AIX@75) (2.8 increase per 1-point increase in HAQ, 95% CI 1.1 to 4.4, p=0.001). Higher rheumatoid arthritis disability was independently associated with increased arterial stiffness, demonstrating a 2.8-point increase in stiffness per 1-point increase in HAQ score.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: